ATE241339T1 - Schäumbare formulierung und schäum - Google Patents

Schäumbare formulierung und schäum

Info

Publication number
ATE241339T1
ATE241339T1 AT95938541T AT95938541T ATE241339T1 AT E241339 T1 ATE241339 T1 AT E241339T1 AT 95938541 T AT95938541 T AT 95938541T AT 95938541 T AT95938541 T AT 95938541T AT E241339 T1 ATE241339 T1 AT E241339T1
Authority
AT
Austria
Prior art keywords
foam
formulation
carrier
foamable
foamable formulation
Prior art date
Application number
AT95938541T
Other languages
English (en)
Inventor
Thomas Gilchrist
Eilidh Gilchrist
Original Assignee
Giltech Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Giltech Ltd filed Critical Giltech Ltd
Application granted granted Critical
Publication of ATE241339T1 publication Critical patent/ATE241339T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/12—Aerosols; Foams
    • A61K9/122—Foams; Dry foams
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/425—Porous materials, e.g. foams or sponges
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/44—Medicaments
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/46—Deodorants or malodour counteractants, e.g. to inhibit the formation of ammonia or bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
    • A61L15/00—Chemical aspects of, or use of materials for, bandages, dressings or absorbent pads
    • A61L15/16—Bandages, dressings or absorbent pads for physiological fluids such as urine or blood, e.g. sanitary towels, tampons
    • A61L15/42—Use of materials characterised by their function or physical properties
    • A61L15/60—Liquid-swellable gel-forming materials, e.g. super-absorbents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Materials Engineering (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Preparation (AREA)
  • Manufacture Of Porous Articles, And Recovery And Treatment Of Waste Products (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Cosmetics (AREA)
  • Materials For Medical Uses (AREA)
  • Iron Core Of Rotating Electric Machines (AREA)
AT95938541T 1994-12-06 1995-12-05 Schäumbare formulierung und schäum ATE241339T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9424562A GB9424562D0 (en) 1994-12-06 1994-12-06 Product
PCT/GB1995/002830 WO1996017595A1 (en) 1994-12-06 1995-12-05 Foamable formulation and foam

Publications (1)

Publication Number Publication Date
ATE241339T1 true ATE241339T1 (de) 2003-06-15

Family

ID=10765469

Family Applications (1)

Application Number Title Priority Date Filing Date
AT95938541T ATE241339T1 (de) 1994-12-06 1995-12-05 Schäumbare formulierung und schäum

Country Status (12)

Country Link
US (1) US6187290B1 (de)
EP (1) EP0797430B1 (de)
JP (1) JPH10509724A (de)
AT (1) ATE241339T1 (de)
AU (1) AU3990095A (de)
CA (1) CA2203367C (de)
DE (1) DE69530939T2 (de)
DK (1) DK0797430T3 (de)
ES (1) ES2200008T3 (de)
GB (1) GB9424562D0 (de)
PT (1) PT797430E (de)
WO (1) WO1996017595A1 (de)

Families Citing this family (104)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9605247D0 (en) * 1996-03-13 1996-05-15 Giltech Ltd Composition
JP2001520274A (ja) * 1997-10-17 2001-10-30 アドバンスト・メディカル・ソリューションズ・リミテッド 発泡材料
US6605751B1 (en) * 1997-11-14 2003-08-12 Acrymed Silver-containing compositions, devices and methods for making
JP4637358B2 (ja) * 1998-10-07 2011-02-23 ギルテック・リミテッド 発泡可能な製剤およびフォーム
US8679523B2 (en) * 1999-12-30 2014-03-25 Kimberly-Clark Worldwide, Inc. Oxygen-delivery closed cell foam matrix for wound treatment
AU2001241644A1 (en) * 2000-02-25 2001-09-03 David Sierra Foam-forming wound dressing
US7137968B1 (en) * 2000-03-13 2006-11-21 Nucryst Pharmaceuticals Corp. Transcutaneous medical device dressings and method of use
US6719987B2 (en) 2000-04-17 2004-04-13 Nucryst Pharmaceuticals Corp. Antimicrobial bioabsorbable materials
US8512718B2 (en) 2000-07-03 2013-08-20 Foamix Ltd. Pharmaceutical composition for topical application
US7255881B2 (en) * 2000-07-27 2007-08-14 Nucryst Pharmaceuticals Corp. Metal-containing materials
US6989157B2 (en) * 2000-07-27 2006-01-24 Nucryst Pharmaceuticals Corp. Dry powders of metal-containing compounds
US20030185901A1 (en) 2000-07-27 2003-10-02 Burrell Robert E. Methods of treating conditions with a metal-containing material
AU2001278322B2 (en) * 2000-07-27 2005-12-22 Smith & Nephew (Overseas) Limited Treatment of hyperproliferative skin disorders and diseases
US20040191329A1 (en) * 2000-07-27 2004-09-30 Burrell Robert E. Compositions and methods of metal-containing materials
US20030206966A1 (en) * 2000-07-27 2003-11-06 Burrell Robert E. Methods of inducing apoptosis and modulating metalloproteinases
US20030180379A1 (en) * 2000-07-27 2003-09-25 Burrell Robert E. Solutions and aerosols of metal-containing compounds
US7008647B2 (en) * 2001-04-23 2006-03-07 Nucryst Pharmaceuticals Corp. Treatment of acne
US7001617B2 (en) 2001-04-23 2006-02-21 Nueryst Pharmaceuticals Corp. Method of induction of apoptosis and inhibition of matrix metalloproteinases using antimicrobial metals
US7427416B2 (en) * 2000-07-27 2008-09-23 Nucryst Pharmaceuticals Corp. Methods of treating conditions using metal-containing materials
US20030211137A1 (en) * 2001-02-21 2003-11-13 David Sierra Foam-forming wound dressing
JP2004529929A (ja) * 2001-04-23 2004-09-30 ニュクリスト ファーマシューティカルズ コーポレーション アポトーシスの誘導およびマトリックスメタロプロテイナーゼの阻害のための金属の使用
JP3950400B2 (ja) * 2001-10-24 2007-08-01 河野製紙株式会社 繊維ウェブ製品、及びその製造方法
US7201925B2 (en) * 2002-04-23 2007-04-10 Nueryst Pharmaceuticals Corp. Treatment of ungual and subungual diseases
IL150907A (en) * 2002-07-25 2007-07-04 Stephan Cherkez Process for the preparation of stable amorphous calcium pseudomonate
CN1678277B (zh) 2002-07-29 2010-05-05 艾克里麦德公司 治疗皮肤病的方法和组合物
US20040110738A1 (en) * 2002-10-22 2004-06-10 Gillis Scott H. Prophylactic treatment methods
IL152486A0 (en) 2002-10-25 2003-05-29 Meir Eini Alcohol-free cosmetic and pharmaceutical foam carrier
US20070292355A1 (en) * 2002-10-25 2007-12-20 Foamix Ltd. Anti-infection augmentation foamable compositions and kit and uses thereof
US8119150B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Non-flammable insecticide composition and uses thereof
US9668972B2 (en) * 2002-10-25 2017-06-06 Foamix Pharmaceuticals Ltd. Nonsteroidal immunomodulating kit and composition and uses thereof
US10117812B2 (en) 2002-10-25 2018-11-06 Foamix Pharmaceuticals Ltd. Foamable composition combining a polar solvent and a hydrophobic carrier
US20080317679A1 (en) * 2002-10-25 2008-12-25 Foamix Ltd. Foamable compositions and kits comprising one or more of a channel agent, a cholinergic agent, a nitric oxide donor, and related agents and their uses
US20080138296A1 (en) 2002-10-25 2008-06-12 Foamix Ltd. Foam prepared from nanoemulsions and uses
US8486376B2 (en) * 2002-10-25 2013-07-16 Foamix Ltd. Moisturizing foam containing lanolin
US7820145B2 (en) 2003-08-04 2010-10-26 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US9211259B2 (en) * 2002-11-29 2015-12-15 Foamix Pharmaceuticals Ltd. Antibiotic kit and composition and uses thereof
US20060193789A1 (en) * 2002-10-25 2006-08-31 Foamix Ltd. Film forming foamable composition
US7704518B2 (en) 2003-08-04 2010-04-27 Foamix, Ltd. Foamable vehicle and pharmaceutical compositions thereof
ES2532906T5 (es) * 2002-10-25 2022-03-23 Foamix Pharmaceuticals Ltd Espuma cosmética y farmacéutica
US20060233721A1 (en) * 2002-10-25 2006-10-19 Foamix Ltd. Foam containing unique oil globules
US20060018937A1 (en) * 2002-10-25 2006-01-26 Foamix Ltd. Steroid kit and foamable composition and uses thereof
US8900554B2 (en) 2002-10-25 2014-12-02 Foamix Pharmaceuticals Ltd. Foamable composition and uses thereof
US20070292461A1 (en) * 2003-08-04 2007-12-20 Foamix Ltd. Oleaginous pharmaceutical and cosmetic foam
US7700076B2 (en) 2002-10-25 2010-04-20 Foamix, Ltd. Penetrating pharmaceutical foam
US9265725B2 (en) 2002-10-25 2016-02-23 Foamix Pharmaceuticals Ltd. Dicarboxylic acid foamable vehicle and pharmaceutical compositions thereof
US8119109B2 (en) * 2002-10-25 2012-02-21 Foamix Ltd. Foamable compositions, kits and methods for hyperhidrosis
US7575739B2 (en) 2003-04-28 2009-08-18 Foamix Ltd. Foamable iodine composition
US20040224981A1 (en) * 2003-05-01 2004-11-11 Nebojsa Janjic Antibacterial methods and compositions
WO2004112852A1 (en) * 2003-06-23 2004-12-29 Beiersdorf Ag Antimicrobial wounddressing
DE10328261B4 (de) * 2003-06-23 2007-10-25 Beiersdorf Ag Desinfizierende Auflage mit Silberbeschichtung und ihre Verwendung
US8795693B2 (en) 2003-08-04 2014-08-05 Foamix Ltd. Compositions with modulating agents
US8486374B2 (en) * 2003-08-04 2013-07-16 Foamix Ltd. Hydrophilic, non-aqueous pharmaceutical carriers and compositions and uses
MXPA06001381A (es) * 2003-08-04 2006-05-19 Foamix Ltd Vehiculo de espuma que contiene un gelificante copolimerico anfifilico.
EP2977043A3 (de) * 2003-08-25 2016-04-06 Foamix Pharmaceuticals Ltd. Eindringender pharmazeutischer schaum
WO2005048946A2 (en) * 2003-11-15 2005-06-02 Creighton University Treatment for burn victims and animal carcasses
AU2005201455A1 (en) * 2004-02-04 2005-08-25 Foamix Ltd. Cosmetic and pharmaceutical foam with solid matter
WO2005084627A1 (en) * 2004-03-01 2005-09-15 University Of Iowa Research Foundation Alcohol-free chlorhexidine compositions
EP1746883A4 (de) * 2004-05-13 2009-07-08 Anthony R Talamonti Medizinisches behandlungskit und verfahren für seinen einsatz
US8361553B2 (en) 2004-07-30 2013-01-29 Kimberly-Clark Worldwide, Inc. Methods and compositions for metal nanoparticle treated surfaces
EP1781098B1 (de) * 2004-07-30 2015-10-07 Avent, Inc. Antimikrobielle geräte und zusammensetzungen
CN101010003B (zh) * 2004-07-30 2012-07-04 金佰利-克拉克国际公司 抗微生物的银组合物
US9289378B2 (en) * 2004-09-20 2016-03-22 Avent, Inc. Antimicrobial amorphous compositions
JP5208507B2 (ja) * 2004-09-23 2013-06-12 ダウ グローバル テクノロジーズ エルエルシー 粘膜又は皮膚医療又は衛生処理システム
DE102005017845A1 (de) * 2005-04-18 2006-10-19 Lohmann & Rauscher Gmbh & Co. Kg Autosterile, antiseptische Kollagenzubereitungen, ihre Verwendung und Verfahren zu ihrer Herstellung
WO2007039825A2 (en) * 2005-05-09 2007-04-12 Foamix Ltd. Saccharide foamable compositions
US20080152596A1 (en) * 2005-07-19 2008-06-26 Foamix Ltd. Polypropylene glycol foamable vehicle and pharmaceutical compositions thereof
DE102006001954B4 (de) 2006-01-16 2013-01-03 Lohmann & Rauscher Gmbh & Co. Kg Antiseptische Alginatzubereitung, Verfahren zu deren Herstellung, sowie deren Verwendung
BRPI0707382A2 (pt) 2006-01-31 2011-05-03 Tyco Healthcare espumas supermacias
US7750201B2 (en) * 2006-04-11 2010-07-06 Tyco Healthcare Group Lp Wound dressings with anti-microbial and chelating agents
US8293965B2 (en) * 2006-04-28 2012-10-23 Kimberly-Clark Worldwide, Inc. Antimicrobial site dressings
US20080014278A1 (en) * 2006-06-30 2008-01-17 Nucryst Pharmaceuticals Metal-containing formulations and methods of use
WO2009007785A2 (en) * 2006-11-14 2009-01-15 Foamix Ltd. Stable non-alcoholic foamable pharmaceutical emulsion compositions with an unctuous emollient and their uses
US20080260655A1 (en) * 2006-11-14 2008-10-23 Dov Tamarkin Substantially non-aqueous foamable petrolatum based pharmaceutical and cosmetic compositions and their uses
PL1986473T3 (pl) * 2007-04-03 2017-07-31 Tsinghua University Organiczne urządzenie elektroluminescencyjne
US8636982B2 (en) 2007-08-07 2014-01-28 Foamix Ltd. Wax foamable vehicle and pharmaceutical compositions thereof
US20090107007A1 (en) * 2007-10-31 2009-04-30 Mitchellace, Inc. Insole with included aloe extract
US20090130029A1 (en) * 2007-11-21 2009-05-21 Foamix Ltd. Glycerol ethers vehicle and pharmaceutical compositions thereof
US9439857B2 (en) 2007-11-30 2016-09-13 Foamix Pharmaceuticals Ltd. Foam containing benzoyl peroxide
US8518376B2 (en) 2007-12-07 2013-08-27 Foamix Ltd. Oil-based foamable carriers and formulations
WO2009072007A2 (en) 2007-12-07 2009-06-11 Foamix Ltd. Carriers, formulations, methods for formulating unstable active agents for external application and uses thereof
US8865227B2 (en) 2007-12-20 2014-10-21 Smith & Nephew (Overseas) Limited Metal carbonate particles and methods of making thereof
GB2456212B (en) * 2008-01-09 2012-04-25 Lrc Products Lubricant mousse
EP2242476A2 (de) * 2008-01-14 2010-10-27 Foamix Ltd. Aufschäumbare pharmazeutische poloxamer-zusammensetzungen mit wirkstoffen und/oder therapeutischen zellen und verwendungen
US20100055437A1 (en) * 2008-08-28 2010-03-04 Tyco Healthcare Group Lp Anti-microbial fibers and related articles and methods
US20100260824A1 (en) * 2008-08-28 2010-10-14 Tyco Healthcare Group Lp Antimicrobial Foam Compositions, Articles and Methods
WO2010117266A1 (en) 2009-04-06 2010-10-14 Broockeville Corporation N.V. In situ gelling alginate systems
WO2010125470A2 (en) 2009-04-28 2010-11-04 Foamix Ltd. Foamable vehicle and pharmaceutical compositions comprising aprotic polar solvents and uses thereof
WO2011013009A2 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surfactant hydro-alcoholic foamable compositions, breakable foams and their uses
CA2769677A1 (en) 2009-07-29 2011-02-03 Foamix Ltd. Non surface active agent non polymeric agent hydro-alcoholic foamable compositions, breakable foams and their uses
WO2011064631A1 (en) 2009-10-02 2011-06-03 Foamix Ltd. Surfactant-free, water-free, foamable compositions and breakable foams and their uses
US9849142B2 (en) 2009-10-02 2017-12-26 Foamix Pharmaceuticals Ltd. Methods for accelerated return of skin integrity and for the treatment of impetigo
US9878143B2 (en) 2010-09-30 2018-01-30 Covidien Lp Antimicrobial luer adapter
US8551525B2 (en) 2010-12-23 2013-10-08 Biostructures, Llc Bone graft materials and methods
DE102012016275A1 (de) * 2011-08-25 2013-02-28 BonaDea Biotechnologie UG (haftungsbeschränkt) Verfahren zum Schützen von Oberflächen
AU2013209432B2 (en) 2012-01-18 2016-11-17 Worldwide Innovative Healthcare, Inc. Modifiable occlusive skin dressing
EP2944565B1 (de) 2014-05-13 2017-09-27 Entrotech, Inc. Erosionsschutzhülle
US10398641B2 (en) 2016-09-08 2019-09-03 Foamix Pharmaceuticals Ltd. Compositions and methods for treating rosacea and acne
US12064510B2 (en) * 2016-12-16 2024-08-20 TDL Innovations, LLC Medical foam for delivery of an active agent
WO2019118458A1 (en) * 2017-12-11 2019-06-20 Respirogen, Inc. Devices and methods for delivery of oxygen to a wound
US11207060B2 (en) 2018-03-16 2021-12-28 Critical Innovations, LLC Systems and methods relating to medical applications of synthetic polymer formulations
WO2021014356A1 (en) * 2019-07-23 2021-01-28 Kci Licensing, Inc. Foam compositions for wound treatment, systems of delivery, and methods of use
CN110628754A (zh) * 2019-10-10 2019-12-31 浙江海洋大学 微生物泡沫型载体及其制备方法、水面石油污染的原位处理方法
US12410293B2 (en) 2022-11-07 2025-09-09 Critical Innovations Llc Systems and methods relating to medical applications of inverse thermosensitive polymer foam formulations
WO2025193852A1 (en) * 2024-03-12 2025-09-18 University Of Iowa Research Foundation Compositions, systems, kits, and methods for treating wounds

Family Cites Families (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4086331A (en) 1975-01-07 1978-04-25 Technion Research And Development Foundation Ltd. Gelatin-based compositions and a method for the generation of stabilized foams therefrom
DE2544777A1 (de) 1975-10-07 1977-04-21 Bayer Ag Dufttraeger auf basis von carboxymethylcellulose-gelen
HU201683B (en) 1987-08-04 1990-12-28 Biogal Gyogyszergyar Process for producing pharmaceutical compositions for promoting healing of wounds
US4948575A (en) * 1989-01-24 1990-08-14 Minnesota Mining And Manufacturing Company Alginate hydrogel foam wound dressing
US5089606A (en) * 1989-01-24 1992-02-18 Minnesota Mining And Manufacturing Company Water-insoluble polysaccharide hydrogel foam for medical applications
US5057606A (en) 1989-01-24 1991-10-15 Minnesota Mining And Manufacturing Company Form-in-place polysaccharide gels
JP2847529B2 (ja) * 1989-07-03 1999-01-20 品川燃料株式会社 銀含有化合物の抗菌性向上方法
JPH04282311A (ja) * 1991-03-08 1992-10-07 Koike Kagaku Kk エアゾール型発泡性傷口消毒剤
US5851461A (en) * 1992-06-19 1998-12-22 Albany International Research Co. Method of producing polysaccharide foams
CA2116037C (en) 1992-06-19 2000-01-04 Dana B. Eagles Method of producing polysaccharide foams
GB9218749D0 (en) 1992-09-04 1992-10-21 Courtaulds Plc Alginate gels
JPH06279268A (ja) * 1993-01-27 1994-10-04 Takeda Chem Ind Ltd 消毒殺菌剤およびこれを含有するエアゾール組成物
US5718916A (en) * 1997-02-03 1998-02-17 Scherr; George H. Alginate foam products

Also Published As

Publication number Publication date
US6187290B1 (en) 2001-02-13
PT797430E (pt) 2003-10-31
EP0797430A1 (de) 1997-10-01
GB9424562D0 (en) 1995-01-25
DE69530939D1 (de) 2003-07-03
DE69530939T2 (de) 2004-05-19
CA2203367A1 (en) 1996-06-13
EP0797430B1 (de) 2003-05-28
CA2203367C (en) 2007-02-06
ES2200008T3 (es) 2004-03-01
DK0797430T3 (da) 2003-09-29
AU3990095A (en) 1996-06-26
WO1996017595A1 (en) 1996-06-13
JPH10509724A (ja) 1998-09-22

Similar Documents

Publication Publication Date Title
ATE241339T1 (de) Schäumbare formulierung und schäum
BR8601296A (pt) Composicao de espuma utilizada no tratamento de papel
MXPA97002401A (es) Agente antiinflamatorio para uso externo.
NO933400D0 (no) Fremgangsmaate for fremstilling av for pellets
ES2149268T3 (es) Procedimiento de estabilizacion de bebidas.
IL100253A0 (en) Nitrogen derivatives
BR9501319A (pt) Composição tópica cosmetica e/ou dermatológica utilização desta composição e processo de tratamento cosmético
NO982721D0 (no) Preserverende oppl°sning
DE69113221D1 (en) Antiatherosclerotische und antithrombotische 2-amino-6-phenyl-4h-pyran-4-one.
BR9611343A (pt) Processo de solubilização d eum agente em um anfifìlico, composição, e, uso da mesma.
PH30665A (en) Aminosulfonyl urea acat inhibitors
SE8502553L (sv) Stabila kompositioner
KR900002802A (ko) 면역억제제로서의 트랜스글루타미나제의 용도
NL7602839A (nl) Werkwijze ter bereiding van een werkzaam bestanddeel voor het veranderen, modificeren of versterken van de organoleptische eigenschappen van bepaalde mate- rialen, alsmede voor het uitvoeren van de laatstge- noemde werkwijze en voor de bereiding van composi- ties, die deze werkzame bestanddelen bevatten.
ATE149573T1 (de) Gerbmittel und gerbverfahren
RU94041028A (ru) Применение производных мелатонина для лечения десинхронизационных нарушений, фармацевтическая композиция
EP0547102A4 (de)
FR2446279B1 (fr) Cis- et trans-3-aryloxy-4-hydroxypyrrolidines et leurs derives, utiles notamment en medecine veterinaire comme antidepresseurs
DE3764559D1 (de) 4-benzyloxy-3-pyrrolin-2-on-1-yl-acetamid, dessen herstellung und verwendung.
UA27708C2 (uk) Аерозольний препарат та спосіб його одержання
AR000922A1 (es) Productos para combatir hongos nocivos que contienen derivados de p-hidroxifenilanilina como agente activo, aplicacion de dichos derivados paracombatir hongos nocivos y procedimiento para combatir hongos nocivos con aplicacion de dichos productos.
ES2102361T3 (es) Dispositivos insecticidas.
IT1293087B1 (it) Microparticelle a base di materiali polimerici ibridi per il rilascio controllato di molecole biologicamente attive, procedimento per la
BG50542A1 (en) Device for massive wood stabilization
HUT57582A (en) Process for producing n-acylated amino-containing compositions suitable for treating burns

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 0797430

Country of ref document: EP